Medicines and Healthcare products Regulatory Agency

An executive agency, also called MHRA

The National Institute for Biological Standards and Control (NIBSC) is part of the Medicines and Healthcare products Regulatory Agency.

348 requests
Make a request to this authority
MHRA updates of clinical trial statuses on EudraCT - progress
Response by Medicines and Healthcare products Regulatory Agency to Till Bruckner on .

Awaiting classification.

Our Ref: FOI 20/273 Dear Till Bruckner, RE: REQUEST UNDER THE FREEDOM OF INFORMATION ACT 2000 Thank you for your enquiry which we received on 6...
MMR
Response by Medicines and Healthcare products Regulatory Agency to Robert Breslin on .

Successful.

Dear Mr Breslin Re: FOI 20/226 Thank you for your email. Please find the response to your request attached. Kind regards Pharmacovigilance Servic...
ICT Strategy
Response by Medicines and Healthcare products Regulatory Agency to C E Mora on .

Awaiting response.

Our Ref: FOI 20/263 Dear C E Mora, RE: REQUEST UNDER THE FREEDOM OF INFORMATION ACT 2000 Thank you for your enquiry which we received on 26 June...
Co-proxamol Inconsistent Pricing
Response by Medicines and Healthcare products Regulatory Agency to James Kelly on .

Partially successful.

Dear Mr Kelly, Thank you for your email. Please find attached the response to your Internal Review. Kind Regards MHRA Customer Service Centre Medi...
Codes for identifying COVID shielded patient list within CPRD
Response by Medicines and Healthcare products Regulatory Agency to A Gibney on .

Information not held.

FOI 20/240 Dear A. Gibney, Thank you for your information request, dated 9th June 2020, where you asked: “Dear Medicines and Healthcare products Reg...
GCP inspection statements documenting serious breaches in 2018
Response by Medicines and Healthcare products Regulatory Agency to Till Bruckner on .

Partially successful.

22^nd may 2020   Dear Requestor,   REF: FOI 20/189   As requested under the Freedom of Information Act, please see below the response to y...
GDP Flexibilities
Response by Medicines and Healthcare products Regulatory Agency to John Watts on .

Awaiting classification.

Dear Mr John Watts,   Thank you for your email.   Please find below answer to the questions you have raised below.   Transportation   T...
Safe Levels of adjuvant within vaccines
Response by Medicines and Healthcare products Regulatory Agency to gavin roberts on .

Successful.

Dear Mr Roberts, Many thanks for your information request dated 5th May where you asked how much adjuvant is currently within the Anthrax vaccine an...
MMR vaccine 2015-2020
Response by Medicines and Healthcare products Regulatory Agency to Marta Jazdzewska on .

Awaiting classification.

Dear Marta Jazdzewska Thank you for your recent Freedom of Information request. Please find a response attached. Kind regards, Chris Penny Pharmaco...
A list of all pharmaceutical manufacturers and suppliers registered with the Medicines & Healthcare products Regulatory Agency
Response by Medicines and Healthcare products Regulatory Agency to Nicola France on .

Successful.

Our Reference: CSC 4897 Dear Nicola France, Thank you for your email. Please review the following link of our website pages for the lists of manuf...
MMR
Response by Medicines and Healthcare products Regulatory Agency to Robert Breslin on .

Awaiting classification.

Thank you for your email.  This auto-response is to inform you that your email has been received and will be reviewed by our Customer Service Team sh...
Request for GMP inspection report for Symbiosis Pharmaceutical Services LTD
Response by Medicines and Healthcare products Regulatory Agency to Amina Al-Mossawi on .

Awaiting classification.

19^th may 2020   Dear Requestor,   REF: FOI 20/178   As requested under the Freedom of Information Act, please find enclosed latest GMP In...
Vaccine-Related Suspect Adverse Reactions
Request to Medicines and Healthcare products Regulatory Agency by Steve Hinks. Annotated by Matt Knight on .

Successful.

This request appears to have been answered at https://www.whatdotheyknow.com/request/adverse_reactions_reported_via_y#incoming-1028452 -- Matt What...
Vaccine Safety Studies for vaccines administered to babies up to 6 months.
Response by Medicines and Healthcare products Regulatory Agency to Jack Parsons on .

Awaiting classification.

Dear Mr Parsons, Please see attached letter. Kind regards FOI Team FOI 20/167 Dear Mr Parsons , Thank you for your information request, dated...
B. Anthracis batches December 1990
Response by Medicines and Healthcare products Regulatory Agency to gavin roberts on .

Information not held.

Dear Mr Roberts, Thank you for your email. We are sorry we cannot help any further but as confirmed in the response provided, the Agency does not ho...
aRMM for buprenorphine misuse, abuse, drug diversion and addiction
Response by Medicines and Healthcare products Regulatory Agency to Lina Masioniene on .

Awaiting classification.

Dear Lina Masioniene FOI 20/156 Thank you for your email. Please see the response to your request attached. Kind regards Pharmacovigilance Service...
Adverse Events
Response by Medicines and Healthcare products Regulatory Agency to John Watts on .

Successful.

FOI 20/064 Dear Mr Watts, Thank you for your email. Please find attached the response to your FOI request. Kind Regards Customer Services Communic...
Mercury Monitor
Response by Medicines and Healthcare products Regulatory Agency to Robyn Duggan on .

Awaiting classification.

Dear Robyn Duggan,   Thank you for your enquiry dated 02 March 2020.   To answer your question directly, MHRA has not issued guidance for the...
Amlodipine
Response by Medicines and Healthcare products Regulatory Agency to Geoff Lovell on .

Long overdue.

Dear Mr Lovell,   Thank you for your recent enquiry to the MHRA.   We have reconsidered our response to include more detail, which we hope wil...
SNBTS Factor IX
Response by Medicines and Healthcare products Regulatory Agency to Sean Cavens on .

Partially successful.

Dear Mr Cavens,   As requested under the Freedom of Information Act, please find below responses to your questions.   We do not hold any infor...
Amount of Aluminium in levothyroxine tablets
Response by Medicines and Healthcare products Regulatory Agency to Linda Sanday on .

Successful.

Dear Ms Sanday,   Thank you for providing us with this reference.   The study refers to Synthroid tablets, which are not licensed in the UK.  We a...
Wholesale Dealers
Response by Medicines and Healthcare products Regulatory Agency to John Watts on .

Successful.

Dear Mr Watt, Thank you for your email. Please find attached your original request and response that was sent to you on 27 December with additional r...
MHRA Factor IX files years 1960 to 1986 inclusive
Response by Medicines and Healthcare products Regulatory Agency to Cressida Haughton on .

Awaiting classification.

Dear Ms Haughton,   Thank you for your further questions.   You stated "Very few batches of Factor IX were tested by NIBSC from its inception in 1...
Human Medicines Regulations - Regulation 28 Suspensions
Response by Medicines and Healthcare products Regulatory Agency to John Watts on .

Successful.

24th January 2020   REF: FOI 19/582   Dear requestor,    Thank you for your Freedom of information request, dated 28th November  2019.  ...
Adverse Incident Reports Involving ECT Machines
Response by Medicines and Healthcare products Regulatory Agency to Nicholas Webb on .

Partially successful.

MHRA reference: FOI 20/003   Dear Nicholas Webb   Thank you for your email of 03 January 2020 in which you asked for the data of all adverse i...

Only requests made using WhatDoTheyKnow are shown. ?